can you take tirzepatide and retatrutide at the same time vs for weight loss Switching from tirzepatide to retatrutide:

Weight gain after stopping Ozempic and other GLP-1 medications is quite common

Indications: Type 2 Diabetes Mellitus (monotherapy or add-on therapy) Especially useful in patients who cannot tolerate metformin or sulfonylureas Can be used in elderly and patients with mild renal impairment Approved Agents in India: Sitagliptin (Januvia) Vildagliptin (Galvus) Saxagliptin (Onglyza) Linagliptin (Trajenta) No renal dose adjustment needed Alogliptin (Nesina) Dosing: Once daily oral dosing Some agents require renal dose adjustment (except Linagliptin) Often combined with metformin or SGLT2 inhibitors Side Effects: Nasopharyngitis, headache GI upset (mild) Rare: Acute pancreatitis, severe joint pain, skin reactions Saxagliptin may slightly increase risk of heart failure in some patients Advantages Over Other Classes: Weight neutral Low risk of hypoglycemia Well tolerated in the elderly Convenient once-daily dosing Limitations: Modest HbA1c reduction (0.50.8%) Not effective in Type 1 Diabetes Less potent than GLP-1 analogs or SGLT2 inhibitors Conclusion: DPP-4 inhibitors are a safe, effective, and well-tolerated option for many patients with T2DM especially those needing an add-on to metformin or who can't tolerate injectables

Here are answers to frequently asked questions about these mouth sores.

An international trade platform called Made in China has agreed to stop unlawful sales of bootleg GLP-1 weight loss drugs into the U.S

GLP-1 receptor agonists are increasingly prescribed to people without obesity for metabolic health and modest weight management

GLP-1 (glucagon-like peptide-1) medications have emerged as a groundbreaking class of drugs, primarily used in the treatment of type 2 diabetes